| 2017-05-31 07:49 | | Drug Channels - Drug Channels News Roundup, May 2017: Express Scripts, WBAD, DIR Fees, JAMA, and #Asembia17 Photos |
| 2017-05-30 07:48 | | Drug Channels - CBI’s Summit on GPO Membership Eligibility and Class of Trade Maintenance |
| 2017-05-23 07:40 | | Drug Channels - A Reality Check on Amazon’s Pharmacy Ambitions |
| 2017-05-22 07:43 | | Drug Channels - Join me at the World Congress Pharma4 Event |
| 2017-05-19 07:43 | | Drug Channels - 340B Purchases Were More Than Half of the Hospital Market in 2016 |
| 2017-05-18 07:57 | | Drug Channels - EXCLUSIVE: The 340B Program Hits $16.2 Billion in 2016; Now 5% of U.S. Drug Market |
| 2017-05-16 07:52 | | Drug Channels - Five Fun Facts About the New Express Scripts-GoodRx Drug Discount Partnership |
| 2017-05-15 07:44 | | Drug Channels - Medicaid Drug Rebate Program (MDRP) Summit 2017 |
| 2017-05-12 07:46 | | Drug Channels - Three Misconceptions about Channel Strategy |
| 2017-05-11 07:54 | | Drug Channels - What I Told HHS Secretary Tom Price About the 340B Drug Pricing Program |
| 2017-05-09 06:43 | | Drug Channels - The State of Specialty Pharmacy 2017: Reflections from #Asembia17 |
| 2017-05-08 07:45 | | Drug Channels - Partnering with IDNs BioPharma Strategy Summit |
| 2017-05-05 07:45 | | Drug Channels - The Weird and Wild Gross-to-Net Adventures of EpiPen and Its Alternatives (rerun) |
| 2017-05-04 07:53 | | Drug Channels - Five Industry Trends for U.S. Drug Wholesalers in 2017 (rerun) |
| 2017-05-03 04:05 | | Drug Channels - Plan Sponsors Like More Transparent PBMs—Yet Not All Choose Transparency (rerun) |
| 2017-05-02 03:14 | | Drug Channels - DIR Fees, Rebates, Pharmacy Economics, and the Future of Medicare Part D (rerun) |
| 2017-05-01 08:19 | | Drug Channels - The Top 15 U.S. Pharmacies of 2016 (rerun) |
